Choroidal Neovascularization in Pathologic Myopia: Three-Year Results After Photodynamic Therapy
Authors:
- Ilse KrebsIKIlse Krebs
- Susanne BinderSBSusanne Binder
- Ulrike StolbaUSUlrike Stolba
- Carl GlittenbergCGCarl Glittenberg
- Werner BrannathWBWerner Brannath
- Alexandra GollAGAlexandra Goll
- 1 September 2005
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 140 (3) , 416.e1-416.e
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatmentAmerican Journal of Ophthalmology, 2004
- Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopiaAmerican Journal of Ophthalmology, 2004
- Effects of verteporfin therapy on central visual field functionOphthalmology, 2004
- Reading Ability and Central Visual Field after Photodynamic TherapyOphthalmologica, 2004
- Myopic choroidal neovascularizationOphthalmology, 2003
- Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopiaOphthalmology, 2003
- Surgical removal of subfoveal choroidal neovascularisation in highly myopic patientsBritish Journal of Ophthalmology, 2001
- Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?British Journal of Ophthalmology, 2000
- PHOTODYNAMIC THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH VERTEPORFINEvidence-Based Eye Care, 2000
- Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularizationOphthalmology, 1999